Vapor Technology Association
Sign In Sign In Sign Out Sign Out
  • Home
  • About
    • About VTA
    • Priorities
    • Governance
    • Industry Marketing Standards
    • FAQ
  • American Impact
  • Membership
  • Action Center
  • News

Vapor Technology Association Vapor Technology Association

Join Today Dashboard
  • Home
  • About
    • About VTA
    • Priorities
    • Governance
    • Industry Marketing Standards
    • FAQ
  • American Impact
  • Membership
  • Action Center
  • News

VTA Announces New Leadership Team

January 11, 2024 by Tony Leave a Comment

VTA’s new leadership is dedicated to advancing the independent vapor industry’s efforts to promote sound science-based regulation that will ensure the future of tobacco harm reduction

WASHINGTON, D.C. – January 11, 2024– The Vapor Technology Association (VTA) today announced the election of new members to its leadership team. The VTA Board of Directors elected Dr. David Johnson, Ph.D, as its new Board President, and elected Charles “Chuck” Melander as its new Treasurer.

“We are proud to welcome both David and Chuck to VTA’s Board and leadership team,” said Tony Abboud, VTA’s Executive Director. “Collectively, David and Chuck bring decades of valuable scientific and regulatory expertise, and bold, visionary leadership to the Vapor Technology Association as we chart the future of tobacco harm reduction and smoking cessation alternatives to cigarettes at the federal and state levels.  I am excited to work with them as we drive our Association’s goals and our core mission of advocating for e-cigarettes as  less harmful alternatives to combustible cigarettes.

Dr. David Johnson

Dr. Johnson is president of VTA member e-LiquidTech, Inc., an industry leading e-liquid and flavor manufacturer and major supplier to the tobacco and vaping industries. Dr. Johnson, a Ph.D in chemistry and analytical chemistry, brings to VTA over 30 years of scientific, regulatory, and management experience, including over 20 years in the tobacco and vape industries at Swedish Match – North America and at Turning Points Brands. Dr. Johnson also serves on the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee (TPSAC) as a small tobacco industry representative. Dr. Johnson’s extensive range of professional experiences and knowledge will support the scientific and regulatory focus and strategy of the Association. 

“It’s an honor and privilege to be recognized among my peers at VTA’s member companies, and I look forward to serving in my new role leading the Association and serving on VTA’s Executive Committee,” said Dr. Johnson. “We know that we have a lot of work to do, and I’m proud to be a part of this great team that has been leading and will continue to lead the charge to provide equitable access to vaping products as an important harm reduction and health equity tool.”

Chuck Melander

Mr. Melander, the Chief Strategy Officer of VTA member Streamline Vape Co., an industry leading e-liquid company, brings an entrepreneurial mindset, with a long record of brand building, driving radical growth, strategic and long-term planning efforts, and regulatory strategy. With a well-tenured career at Swedish Match and Turning Point Brands, where he served on the Executive Teams that drove rapid growth within the companies, Mr. Melander developed strong expertise in less harmful nicotine alternatives to cigarettes. Mr. Melander, a biochemist by training, has also served as an alternate member of TPSAC. Mr. Melander has an acute understanding of the legal and regulatory framework at both the federal and state levels.

“I am excited to take on this new challenge at VTA and move into a role which allows me to bring my experience in the vaping and tobacco industries to advance commonsense policies which support the broad access for responsible adult use of vaping products,” said Mr. Melander. “I thank the VTA Board for this nomination, and I look forward to working with the rest of the Executive Committee and the Board to advance VTA’s critically important mission.”

“On behalf of the VTA Board, I would also like to thank George Cassels-Smith, CEO of Tobacco Technology Inc and e-LiquidTech, Inc., for the steady and thoughtful leadership he has provided to VTA over the past three years and for the sound guidance he has provided me,” said Tony Abboud.  Under Mr. Cassels-Smith’s leadership, VTA was able to weather the organizational challenges presented by the pandemic, restore VTA’s footing as a leading voice for rational science-based regulation of less harmful nicotine products, and establish a strong direction for the future.  “The vaping industry owes Mr. Cassels-Smith a debt of gratitude for his past and continuing commitment to VTA and our common mission.”

Dr. Johnson and Mr. Melander assumed their new roles in December and, together with Jon Glauser, who also was re-elected by the Board as VTA’s Secretary, will serve on VTA’s Executive Committee.

David Johnson
Chuck Melander

# # #

About VTA: The Vapor Technology Association is the leading industry trade association in the United States whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Filed Under: News, Press Releases Tagged With: vaping association

VTA Response to the 5th Circuit En Banc Opinion Rebukes the FDA’s “De Facto Ban on Flavored E-Cigarettes”

January 8, 2024 by Tony

STATEMENT FROM THE VAPOR TECHNOLOGY ASSOCIATION IN RESPONSE TO THE FIFTH CIRCUIT COURT OF APPEALS OPINION IN WAGES AND WHITE LION INVESTMENTS, LLC (DBA TRITON DISTRIBUTION) V. U.S. FOOD & DRUG ADMINISTRATION:

The following statement is attributable to Tony Abboud, executive director of the Vapor Technology Association:

“The en banc opinion of the United States Court of Appeals for the Fifth Circuit that was released last Wednesday is nothing less than a blistering indictment of the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) for its intentional misleading of the U.S. e-cigarette industry and unlawful manipulation of its own pre-market tobacco application (PMTA) regulatory process. To use the language of the court, “Over several years, the Food and Drug Administration (“FDA”) sent manufacturers of flavored e-cigarette products on a wild goose chase,” in search of an approval that the FDA admitted in court it was never, ever, going to grant.

“The court was so stupefied by the FDA’s bad-faith efforts to reject all flavored e-cigarette products it cited Shakespeare to illustrate the full extent of the FDA’s disingenuity, particularly after the court explained that the plaintiffs in that case provided scientific evidence that e-cigarettes “save lives”. The court also emphasized the dramatic and abrupt “FDA flip-flop” which led to the implementation of what the court called a “de facto ban” on flavored e-cigarette products in the U.S. This was in addition to the voluminous jurisprudence cited by the court laying bare just how egregious the behavior of the FDA administrative state has been towards e-cigarette products and the consumers that use them. As the court stated, “No principle is more important when considering how the unelected administrators of the Fourth Branch of Government treat the American people.”

“The ruling by the Fifth Circuit’s en banc panel makes the recent release of the CTP five-year strategic plan – a case study in bureaucratic posturing – essentially null and void.  Nothing in the strategic plan demonstrates that the FDA acknowledges its past and recurring failings or, to the extent that it does, has any commitment to using its enormous regulatory power to authorize less harmful flavored e-cigarette products to save lives.  Worse, the strategic plan completely failed to address the central criticism of the Reagan-Udall Foundation that the FDA has failed to explain what evidence it demands to authorize e-cigarettes as “appropriate for the protection of public health” or otherwise explain how the agency is even interpreting or applying that legal standard.  And worst of all, the strategic plan reveals that FDA has no plan or intent to speak factually to the American public about the benefits of switching from smoking to vaping at any time in the near future.

“Compared to the diametrically opposite approach taken in England – where the government has authorized more than a million flavored e-cigarette products, is telling smokers to use e-cigarettes to quit smoking, and is giving away e-cigarette starter kits to one million of its smokers as part of its ‘Swap to Stop’ program designed to end smoking by 2030 – the U.S. FDA is locked in an anti-scientific ideologically prohibitionist mentality which will ensure that millions of Americans will continue to suffer from smoking related diseases and die from cigarette smoking every year.

“The Vapor Technology Association renews its call for FDA and specifically CTP to reverse course, follow the law, and restore scientific primacy and integrity to its regulatory process by rapidly reviewing and approving the pending flavored e-cigarette PMTAs in accordance with this latest demand by the Fifth Circuit.”

Media Contact
press@vaportechnology.org

About VTA

The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Also Read FDA’s Center for Tobacco Products Must Reverse Course to Quickly Reduce Smoking Harms

Filed Under: News, Press Releases

VTA Response to CTP 5 Year Strategic Plan

December 19, 2023 by Tony Leave a Comment

The Vapor Technology Association has reviewed the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) five-year strategic plan. In short, VTA is deeply disappointed with the plan’s lack of substance and absence of specifics to move American smokers off of combustible products towards effective harm-reduction nicotine options.

In October, at the Food & Drug Law Insitute’s Tobacco and Nicotine Policy Conference in Washington, D.C., VTA called on FDA to make harm reduction the “north star” of the strategic plan. The plan that has now been released lacks any commitment, much less a clear roadmap, to aggressively move people who smoke towards non-combustible forms of nicotine. It speaks vaguely about the importance of health equity and insists that a primary focus of CTP remains on reducing tobacco-related death and disease – but provides no insight, details, or specific methods by which CTP will achieve this. Nor does it acknowledge the latest science in support of e-cigarettes as the most effective non-combustible option for smoking cessation.

Most concerning is that CTP’s strategic plan fails to even attempt to address the Reagan Udall Foundation’s (RUF) central and most damning criticisms that go to the core of CTP’s job:

  1. that CTP has not clearly met the most basic elements of its tobacco and nicotine regulatory program by defining what is required of applicants under the “Appropriate for the Protection of the Public Health” (APPH) standard in the Tobacco Control Act, and
  2. that CTP has not clearly explained how it is assessing the science to determine what is APPH.

The silence of CTP’s strategic plan on these issues is defeaning. By failing to address these core criticisms, CTP’s five-year strategic plan will continue to generate misinformation, inefficiency, litigation, and suspicions of political interference.

VTA has repeatedly called on CTP to speak immediately, loudly, and repeatedly to adults about tobacco harm reduction in order to start saving lives now. Instead, CTP mentions the notion of conducting “foundational” and “formative” research on whether it might speak to adults – at some unknown time in the future – about harm reduction and less harmful vaping and other nicotine alternatives. Meanwhile, 480,000 people die prematurely every year from cigarette smoking.

The release of CTP’s five-year strategic plan, which took a full year to construct, was an opportunity to demonstrate bold, not bureaucratic, leadership on tobacco harm reduction that could close the deadly chapter of cigarettes in America. Instead, what the American public was given is document that reflected little more than a commitment to bureaucracy without any real direction or goals, much less a strategy to achieve those goals. Only 15 of the 27 pages of government pabulum (littered with pictures, graphics, and process tables) could actually be considered a recitation of the “plan” but, in total, it revealed nothing more than a “check the box” exercise (which failed to even check the most important boxes).

The strategic plan was a huge missed opportunity for the bureacracts to stand up for science and tobacco harm reduction, and stand up for the millions of smokers in vulnerable Black, LGBTQ+, and low income popluations who would benefit the most from a plan that actually kickstarted the important work of improving and saving lives and reducing or eliminating smoking related diseases. Instead, CTP demonstrated that its hands are firmly gripped upon a wheel that it is refusing to turn as it careens off a public health cliff with the lives of American smokers in tow.

Filed Under: Government Updates, News, Press Releases

NEW POLL: American Public Grossly Misinformed About Benefits of E-Cigarette Use to Smokers & Low Risk of Vaping

November 30, 2023 by VTA Editors

New polling conducted by KAConsulting, LLC, led by U.S. presidential advisor and market analytics expert Kellyanne Conway, reveals misinformation from public health institutions around e-cigarettes creates significant confusion for American public.

WASHINGTON – November 30, 2023 – The Vapor Technology Association (VTA) today
released new polling from pollster Kellyanne Conway, which reveals a significant information
gap in public perception versus reality regarding e-cigarettes being an effective tool for adults in
need of smoking cessation and harm reduction alternatives.

The poll is a national online survey of 1,000 registered U.S. voters, including 35% Republicans;
35% Democrats; 16% independents; and 14% unaffiliated. VTA’s polling sought to better
understand the current state of Americans’ knowledge, perceptions, and opinions on e-cigarette
use, including perceptions of where vaping lies among other risky behaviors, like smoking
cigarettes, drinking alcohol, and smoking marijuana.

The poll confirms what many scientists and academics have lamented for years: The American
people are overwhelmingly misinformed by public health institutions, such as the U.S. Food and
Drug Administration’s Center for Tobacco Products (CTP), on the dramatically lower risks and
significant benefit tradeoffs of vaping nicotine versus smoking cigarettes, which kill nearly half a
million Americans every year.

When provided factual information about e-cigarettes, public perception of vaping skewed from
largely negative towards a demonstrable openness around the potential benefits of e-cigarettes,
particularly for current smokers. Additionally, the poll demonstrates that Americans, despite their
overwhelmingly negative views on e-cigarettes, ranked numerous other behaviors and lifestyle
choices, like drinking alcohol or smoking marijuana, as much riskier.

“The poll that VTA conducted with Kellyanne and her team underscores what we have argued for years: that public health officials and lawmakers must follow the science when it comes to vaping and stop misinforming the public about the benefits and relative risks of e-cigarettes and other non-combustible nicotine products, especially as an effective harm reduction tool for those who currently smoke cigarettes,” said Tony Abboud, executive director of VTA. “This watershed polling demonstrates the clear and present danger of this public health misinformation gap that needs to be addressed.”

“This poll demonstrates the effect of information underload combined with unaddressed confusion about an issue – the result is chaos,” said Kellyanne Conway. “Yet, when Americans are provided accurate information about e-cigarette use, their opinion shifts dramatically. This shows the power of politicized science versus actual science.”

Key findings included in the polling’s results:

  • An overwhelming majority of Americans (84%) have a negative view of vaping nicotine and 78% wrongly believe that vaping nicotine is as or more dangerous than smoking cigarettes.
  • When informed that vaping is more effective than nicotine replacement therapies such a nicotine gums and patches in helping adult smokers quit, 37% of respondents say they are less likely to support a ban.
  • When informed of the United Kingdom’s “Swap to Stop” program of handing out free vaping starter kits to help people stop smoking, 40% of Americans say they would be more likely to support such a program in the U.S.
  • More than half of Americans (53%) say FDA’s rejection of 99% of e-cigarette applications while approving cigarettes over vaping products at a rate of 45 to 1 is unreasonable policy.
  • A majority of Americans (79%) state that banning e-cigarettes would just result in a black market for people to continue buying and selling nicotine vaping products.
  • Half of Americans (49%) say it is unreasonable policy for FDA to use youth vaping as a reason to ban flavored e-cigarettes when FDA also says youth vaping is not an epidemic.
  • More than half (56%) of Americans believe that FDA is making unfair decisions or playing politics about tobacco and vaping and should return to focusing on protecting public health.
  • Only 35% of Americans say FDA should continue on its current path with respect to tobacco and vaping.
  • Vaping nicotine is considered the least dangerous activity (7%) to a person’s life when compared to other activities, like using illegal drugs, not wearing a seatbelt in a car, poor nutrition, and drinking alcohol.

The FDA’s CTP sets tobacco and e-cigarette policy in the U.S. The use of selective science to
justify agenda-driven decisions regarding e-cigarettes or any other less harmful non-
combustible product is ultimately dangerous to public health and confusing for millions of
Americans looking to quit smoking. This new data reveals the extent of this confusion and the
fact the majority of Americans think that FDA is heading in the wrong direction with its e-
cigarette and tobacco policy.

“This polling clearly demonstrates that the FDA’s Center for Tobacco Products has been successful in creating confusion around vaping in the U.S., and when provided the facts, the majority of Americans believe that FDA’s current trajectory of banning virtually all e-cigarettes is the wrong policy which is driven by political and not scientific rationale,” concluded Mr. Abboud.

“VTA looks forward to working with all regulators to correct the record, get the right information about vaping benefits to American consumers, and help reset the FDA’s skewed agenda on less harmful nicotine products based on science and common-sense solutions.”

For more information and a complete copy of the poll, follow the link below.

View Complete Poll Results (PDF)

About VTA

The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Also Read VTA’s Executive Director Addresses the 2023 National Youth Tobacco Survey

Filed Under: Press Releases

VTA Issues Statement Criticizing FDA Inspection Blitz Announcement

June 25, 2023 by VTA Editors

Vapor Trade Group Warns Against What it Says Is FDA Misinformation That Jeopardizes Harm Reduction Mission

WASHINGTON, June 23, 2023 (Newswire) – Following the FDA’s announcement of what it called a “nationwide retailer inspection blitz” which targeted 189 small business retailers, Vapor Technology Association Executive Director Tony Abboud released the following statement:

“The actions this week by the FDA demonstrate once again that it has no control over the market it is charged with regulating. FDA’s announcement unfairly targets small business owners while offering its tacit support of the biggest companies. FDA currently operates with a de facto policy to remove all non-tobacco flavored vaping products from the market, while it continues to approve combustible tobacco products at an alarming rate. FDA has a responsibility to create a marketplace that allows the most innovative products that adults actually want to use, not arbitrarily pick winners and losers due to pressure from political officials.”

FDA synchronized its “blitz” announcement with not one, but two CDC reports, which misrepresent the real trends in youth vaping. One study cited by FDA was conducted with an agenda driven special interest group and funded by a prominent billionaire. The CDC’s own National Youth Tobacco Survey has shown the dramatic reduction in youth e-cigarette use. Since its peak in 2019, vaping is down 50% amongst high schoolers and 70% amongst middle schoolers, and now sits at 2014 levels.

In fact, Brian King, the Director of the Center for Tobacco Policy (CTP), has stated publicly that CTP no longer considers youth vaping an epidemic. This is welcome news. And given these facts, the reported “rise” in flavored vape sales must necessarily be amongst adults who either desire or need less harmful alternatives to cigarettes.

“FDA has also misused scant data from a second CDC study to sensationalize the risk to small children by claiming a supposed increase in poison control calls – the overwhelming majority of which – 99.8% – had no major effect. This sleight of hand is being used to justify its actions against just one product while at the same time ignoring the data showing two other vaping products owned by cigarette companies were also specifically identified in the study.”

Given the known dangers of smoking, FDA must take a stronger stance on cigarettes than it does on vaping. Instead, the FDA has authorized the sale of 900 new cigarette products, two-thirds of which are owned by the biggest tobacco companies. The FDA can no longer, in good conscience, continue down this path.

34 million adults are addicted to cigarettes – the only product which when used as intended will kill you. By selectively targeting vaping, FDA is working overtime to eliminate effective harm reduction options for adults and ensuring the only option for many will be to continue smoking.”

About VTA

The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Filed Under: Press Releases

VTA Files SCOTUS Brief Supporting Avail Vapor’s 4th Circuit Appeal

June 17, 2023 by Tony

WASHINGTON, June 18, 2023 – On June 14, 2023, the Vapor Technology Association (VTA) filed an amicus curiae brief with the Supreme Court of the United States in the case Avail Vapor, LLC, et al. v. US Food & Drug Administration. The brief was filed in support of Petitioners’ – Avail Vapor and Blackbriar Regulatory Consulting – Petition for Writ of Certiorari seeking Supreme Court review of the Marketing Denial Orders issued to Petitioners in connection with their open-system flavored vaping products. VTA’s amicus brief encouraged the Supreme Court to take up the case because it will have “major public health and economic impacts that will dramatically affect millions of Americans.”

The Supreme Court Avail

First, VTA explained that only one week after the Fourth Circuit’s decision upholding the MDOs, an Independent Tobacco Expert Panel released its report on FDA’s Center for Tobacco Products which revealed serious regulatory failings of the agency, including those specifically raised by Petitioners in the Supreme Court Petition. The report which roundly crticized the FDA’s handling of pre-market tobacco applications, like those at issue in the Petition, had been called for by FDA Commissioner Robert Califf himself.

Second, VTA explained that the world’s leading tobacco and nicotine researchers have undermined the scientific underpinnings of the FDA’s decision-making rationale, and called into question the public health objectives of removing flavored ENDS products from the market, making review by the Court important not to simply re-examine the science (which courts generally will not do), but to evaluate the propriety of the highly questionable process used by FDA to implement the requirements of the Tobacco Control Act.

Third, VTA explained that the independent vapor industry comprises more than 10,000 companies across the United States and is responsible for generating more than 130,000 jobs and more than $22 billion in economic activity for the U.S. economy – an industry that would be devastated by FDA’s continued march to ban flavored ENDS. VTA also explained the results of its expert economists’ analysis that FDA’s removal of all flavored vaping products from the market would lead to the shutdown of close to 10,000 businesses, causing the loss of 99,158 full-time equivalent jobs, the loss of $5,258,906,715 in wages and benefits, and the loss of $16,449,776,269 to the U.S. economy, all of which makes the issue before the Court important for consideration.

The goal of the brief is to encourage the Supreme Court to take up the case petitioning for review. Our hope is that our amicus brief offers the Supreme Court additional context and rationale for why reviewing FDA’s actions is exceptionally important. Read the brief or download here:

22 1112 Amicus Brief Of Vapor Technology Association

ABOUT VTA
The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Filed Under: News, Press Releases

VTA Responds to the Final Reagan-Udall Foundation Report

February 24, 2023 by Ethan D'Souza

Leading Vape Trade Association Raises Concerns Over Continued Political Interference at the Center for Tobacco Policy 

WASHINGTON, FEBRUARY 24, 2023 –  Following the FDA’s response to the
Reagan-Udall Foundation’s critical report, Vapor Technology Association Executive Director Tony Abboud released the following statement:

“The FDA’s response to the Reagan-Udall Report highlights deep, structural problems with the CTP leadership and its operations. The agency’s response does not give any confidence that the biggest problem – the ongoing interference in the scientific process by political officials will ultimately be addressed – particularly since CTP continued this practice after the Reagan-Udall Foundation report was issued.”

“Tellingly, CTP has acknowledged that it operates with no long-term strategic plan yet at the same time turns around and asks for more money both in the form taxpayer funded appropriations as well as $100M in ‘user fees’. Under no circumstances should Congress consider appropriating even more money to an agency bureaucracy that operates with a such a concerning lack of transparency and without a long-term strategic plan in place.”

“To be clear, the request for user fee funding would require passage of a new federal excise tax that ultimately will be passed on to consumers in violation of President Biden’s pledge of no new taxes. According to the FDA, every single manufacturer is selling illegal products (because FDA has only authorized a handful of e-cigarettes). Yet, FDA has no concern about government imposing and collecting new taxes on illegal products to fund their bureaucracy.”

“Unfortunately, CTP currently operates with a de facto policy that denies market approval to any non-tobacco flavored vaping products. This goes against the preponderance of the scientific evidence, including CTP’s own internal documentation, that concluded flavored vaping products are effective tools to help adult smokers quit. Since 2010, when e-cigarettes became widely available in the US, we have seen adults who smoke drop by a remarkable 62 percent. Flavored e-cigarettes should be a key part of the Administration’s cancer moonshot. Unfortunately, CTP seems determined to drive smokers to the riskiest of all nicotine devices – combustible cigarettes – and, while the devil is in the details, nothing in today’s announcement hinted at any material shift in FDA’s perpetual attack on every nicotine containing product.”

ABOUT VTA
The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to innovating and selling high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

MEDIA CONTACT
press@vaportechnology.org

Filed Under: News, Press Releases

VTA Responds to the Final Reagan-Udall Foundation Report

December 20, 2022 by Tony

Leading Vapor Trade Group Urges FDA to Adopt Reforms to Protect Sanctity of Scientific Process 

WASHINGTON, December 20, 2022 (Newswire.com) – Following the Reagan Udall Foundation release of their final report reviewing the operations of FDA’s tobacco program, the Vapor Technology Association, through its Executive Director Tony Abboud, released the following statement: 

“The Reagan-Udall Foundation’s independent review of FDA’s tobacco program has uncovered systemic problems inside the Center for Tobacco Products that allowed political decisions to override the science-based recommendations of FDA professional staff concerning the authorization of vaping products that would provide safer alternatives for adult smokers looking to quit combustible cigarettes.  

“The Reagan-Udall review was requested by FDA Commissioner Califf to address problems with the Center for Tobacco Products (CTP) programs for regulations and guidance, application review, compliance and enforcement, and communication with the public and other stakeholders. Their observations included the following:

  • CTP has no strategic plan and must create one that identifies the Center’s strategic objectives and plots an operational roadmap to achieve them.
  • CTP must resolve how to weigh the public health benefits of adults who use ENDS that will completely quit smoking combustible tobacco products against the potential public health harms to youth who use ENDS.
  • CTP has not clearly articulated what is required to meet the appropriateness for the protection of public health standard.
  • CTP struggles to function as a regulator due to some of its own policy choices.
  • CTP faces significant challenges in clearing policies through the career and political infrastructure.
  • CTP lacks consistent implementation of its own policies, particularly with respect to harm reduction.
  • CTP has not been transparent regarding its failure to clear the market of illegal products.
  • CTP’s current goals and priorities are unclear in communication and practice.

“The Vapor Technology Association has raised concerns for years about the opaque and questionable operations of the CTP. Reagan-Udall’s review highlights a shifting and arbitrary decision-making process, untethered from science due to political or external pressures, that has damaged the marketplace for safer vaping products, impaired the FDA’s credibility, undermined the FDA’s mission of harm reduction by denying millions of American smokers truthful information and authorized products. We are pleased to see many of the recommendations VTA provided to the Reagan-Udall Foundation reflected in the Foundation’s report.

“The fact that CTP has continued to issue major decisions despite deficiencies highlighted by Reagan-Udall is highly questionable. VTA agrees that ‘CTP must invest the time, now…to create and implement a Strategic Plan’ and that ‘the path to resolving many of the Center’s current challenges starts with establishing the scientific and policy framework to make clear and timely product decisions.’ For that reason, the FDA Commissioner should instruct CTP to stand down on issuing any further denials of less harmful nicotine alternative product applications until CTP has been able to review and implement the safeguards and recommendations made by the Reagan-Udall Foundation, and VTA stands ready to assist FDA and CTP by providing the necessary stakeholder input that the Foundation also said was necessary,” said Tony Abboud.

ABOUT VTA
The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners. Source: Vapor Technology Association

Filed Under: News, Press Releases

The VTA Submits Supreme Court Amicus Brief on Vaping Flavor Ban

November 16, 2022 by VTA Editors

WASHINGTON, November 15, 2022 (Newswire.com) – On Nov. 8, 2022, voters in California passed a ballot initiative (Proposition 31) upholding a 2020 law banning the sale of most flavored tobacco products. On Nov. 9, 2022, R.J. Reynolds (RJR), filed a federal lawsuit challenging California’s ban as being unlawfully preempted by the Family Smoking Prevention and Tobacco Control Act of 2009, (TCA). Yesterday, the Vapor Technology Association (VTA) filed an amicus brief with the Supreme Court of the United States in support of a Petition for Writ of Certiorari in another RJR case asserting similar arguments against the earlier L.A. County ordinance banning all flavored tobacco products. Supreme Court review is critical for two reasons.

First, the “substantial effect on the Nation’s economy” created by the sale of tobacco products is of great significance. The passage of the TCA in 2009 led to the creation of a new, independent distribution chain of companies, including manufacturers, distributors, suppliers, and retailers, that has steadily grown outside of the traditional tobacco products industry, offering their customers non-combustible nicotine vapor products as alternatives to smoking cigarettes. According to a new economic impact report (prepared by John Dunham & Associates), the independent vapor industry comprises more than 10,000 companies across the United States and is responsible for generating more than 130,000 jobs and more than $22 billion in economic activity for the U.S. economy.

This industry would be devastated by unrestricted flavor bans, given its unique and substantial reliance on the sale of flavored vapor products to adult consumers. Importantly, the potential shutdown of close to 10,000 businesses, causing the loss of 99,158 full-time equivalent (FTE) jobs, the loss of $5,258,906,715 in wages and benefits, and the loss of $16,449,776,269 to the U.S. economy makes the issue before the Court incredibly important. In the state of California, where the majority of e-liquid manufacturers of the independent vapor products industry are based, losses would total approximately 6,925 FTE jobs, paying $445,565,776 in wages and benefits, and the economic output of the California economy would be diminished by $1,497,332,882 if flavored vapor products could not be sold. 

Second, since the passage of the L.A. County Ordinance – leading tobacco-control scientists have challenged the notion of banning flavored e-cigarette flavors and have warned that decreasing availability of flavored vaping products harms the ability of adult smokers to quit smoking cigarettes. Instead of blanket bans, these tobacco-control scientists endorse alternative time, place and manner restrictions for the sale of flavored vaping products.

Permitting local and state governments to implement unscientific bans that directly interfere with the fundamental purpose of the TCA and would overrule the FDA’s decision-making for products deemed appropriate for the protection of public health, is not only unlawful, but is dangerous from a public health perspective, in VTA’s view.

ABOUT VTA
The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Filed Under: News, Press Releases

Vapor Association Challenges FDA’s Youth Vaping Analysis

October 7, 2022 by Tony Leave a Comment

Vape Trade Group Warns That Latest FDA Action Risks Jeopardizing Agency Credibility and Harm Reduction Mission

WASHINGTON, October 7, 2022 (Newswire.com) – Following the Food and Drug Administration’s release of the National Youth Tobacco Survey, Vapor Technology Association Executive Director Tony Abboud released the following statement: 

“Yesterday, the FDA, in coordination with the CDC, released new data from the 2022 National Youth Tobacco Survey (NYTS) on e-cigarette use among U.S. youth. The FDA represents the NYTS data to show that youth vaping ‘remains high,’ yet a deeper dive into the data show only a small uptick in experimental or infrequent use while regular use remains flat or is slightly down. 

“The fact remains that since 2019, according to the CDC, the number of high school students who have tried vaping (1 time in the last 30 days) has dropped by 50%, and the number of middle school students has plummeted by 70%. During that same time period, the number of high-school students who ‘frequently’ vape has dropped by 37% and the number of middle school students has dropped by 65%. FDA’s near single-minded focus on youth who experiment with vaping versus those who are frequent users ignores what clearly is a consistent trend of youth away from vaping products. Rather than focusing on removing products from the market in an attempt to impact youth vaping, the FDA should instead support common-sense regulatory reforms that would better restrict access to products instead. Simply removing products from the market is not the answer when those products are also proven to help adult smokers quit. 

“It is well documented that flavored vapor products help adult smokers to switch to less harmful vaping and study after study after study has confirmed this. Since 2010, when e-cigarettes became widely available in the U.S., smoking rates have declined by more than half. Tobacco use is down. Youth vaping is down. These are both good things and are not in dispute. Unfortunately, there are still 40 million Americans addicted to cigarettes. Every year, 500,000 die from smoking-related diseases and yet less than three percent of our kids are using vapes on a regular basis. The FDA’s failure to acknowledge this reality ignores the role vaping plays in harm reduction and smoking cessation, and puts more lives at risk.”

ABOUT VTA
The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

MEDIA CONTACT
press@vaportechnology.org

Filed Under: News, Press Releases

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Follow Us

  • Twitter
  • YouTube
  • Facebook

Copyright © 2024 Vapor Technology Association.
All Rights Reserved.

Privacy Policy |
Terms Of Use

Created by Black

Association

  • About VTA
  • Priorities
  • Governance
  • FAQ
  • News

Resources

  • Reports
  • Action Center
  • Economic Impact
  • Additional Resources

Action

  • Become A Member
  • Action Center
  • Subscribe to VTA Insider
  • American Impact
  • Contact

Let’s Connect

Loading

Subscribe to VTA

Loading

Myth vs Fact

Continue to VTA